AngioDynamics ANGO Income Statement
| TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | ||
|---|---|---|---|---|---|---|
| $313.73M+10.7% | $307.31M+7.3% | $300.72M+2.7% | $292.5M-3.8% | $283.32M-12.6% | ||
| $143.39M+10.9% | $139.59M+3.0% | $137.88M-2.5% | $134.79M-9.7% | $129.32M-19.9% | ||
| $170.34M+10.6% | $167.72M+11.1% | $162.84M+7.6% | $157.71M+1.9% | $154M-5.3% | ||
| 54.3%-0.1pp | 54.6%+1.9pp | 54.1%+2.4pp | 53.9%+3.0pp | 54.4%+4.2pp | ||
| $27.86M+5.7% | $27.69M+0.2% | $26.35M-11.7% | $26.22M-16.8% | $26.36M-19.3% | ||
| $108.72M+7.3% | $106.78M+5.5% | $105.66M+4.6% | $103.14M+0.3% | $101.28M-3.1% | ||
| $43.66M+3.2% | $43.43M+2.5% | $43.67M+5.8% | $42.09M+2.3% | $42.3M+3.3% | ||
| $205.86M+1.6% | $200.26M-49.5% | $200.35M-49.7% | $197.66M-50.8% | $202.62M-51.3% | ||
| -$35.52M+26.9% | -$32.54M+86.4% | -$37.51M+84.4% | -$39.95M+79.2% | -$48.62M+75.5% | ||
| -11.3%+5.8pp | -10.6%+72.7pp | -12.5%+69.7pp | -13.7%+49.7pp | -17.2%+44.2pp | ||
| -$191K-147% | $32K+126% | $368K+141% | $978K+161% | $408K+379% | ||
| —— | —— | —— | —— | $4.94M— | ||
| -$31.38M+25.4% | -$27.71M+88.3% | -$32.21M+86.5% | -$34.03M+82.2% | -$42.06M+78.9% | ||
| $12K+102% | -$2K+100.0% | -$107K-103% | -$39K+99.5% | -$671K+90.4% | ||
| -$31.39M+24.2% | -$27.71M+87.7% | -$32.1M+86.8% | -$33.99M+81.6% | -$41.39M+78.5% | ||
| -10%+4.6pp | -9%+69.4pp | -10.7%+72.3pp | -11.6%+49.0pp | -14.6%+44.8pp | ||
| -$0.75+25.7% | -$0.67+88.0% | -$0.78+87.1% | -$0.83+81.8% | -$1.01+78.9% | ||
| -$12.33M+43.5% | -$8.62M+95.9% | -$12.48M+94.1% | -$14.15M+91.4% | -$21.83M+87.2% | ||
| -3.9%+3.8pp | -2.8%+70.7pp | -4.1%+68.5pp | -4.8%+49.4pp | -7.7%+44.9pp | ||
| -$35.52M+26.9% | -$32.54M+86.4% | -$37.51M+84.4% | -$39.95M+79.2% | -$48.62M+75.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is AngioDynamics's revenue?
- AngioDynamics (ANGO) generated $313.7M in revenue over the trailing twelve months, up 10.7% year over year.
- Is AngioDynamics profitable?
- AngioDynamics is not currently profitable: it reported a net loss of $31.4M over the trailing twelve months, a -10.0% net margin.
- What are AngioDynamics's profit margins?
- Gross margin is 54.3% and operating margin is -11.3%, with a -10.0% net margin.
- What is AngioDynamics's earnings per share?
- AngioDynamics's diluted EPS over the trailing twelve months is $-0.75.
- Where does AngioDynamics's income statement data come from?
- Every line is extracted from AngioDynamics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
